| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 18, 2020Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T...
-
May 15, 2020
Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to...
-
April 22, 2020
Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans...
-
March 31, 2020
In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be...
-
January 28, 2020
Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...
